Lucia Mastrullo

The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate [see comments]

R. De Biasi, Angiola Rocino, E. Miraglia et al. · Blood · 1991 · 99 citations · Full text

Medicine, Hematology, Immunology +10

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party

Giovanni D’Arena, Caterina Giovanna Valentini, Giuseppe Pietrantuono et al. · Annals of Oncology · 2011 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Incidence of Factor VIII Inhibitor Development in Hemophilia A Patients Treated with Less Pure Plasma Derived Concentrates

R. De Biasi, Angiola Rocino, M. L. Papa et al. · Thrombosis and Haemostasis · 1994 · 70 citations

Medicine, Hematology, Clinical Pharmacology +13

Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy

Gaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone et al. · British Journal of Haematology · 2011 · 58 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +10

Epidemiology of the delta globin alleles in southern Italy shows complex molecular, genetic, and phenotypic features

Maria De Angioletti, Giuseppina Lacerra, Carlo Gaudiano et al. · Human Mutation · 2002 · 28 citations

Life Sciences, Genetics, Molecular Genetics +12